Skip to main content
Cidara Therapeutics, Inc. logo

Cidara Therapeutics, Inc. — Investor Relations & Filings

Ticker · CDTX ISIN · US1717572069 LEI · 549300IHQ9Z7RI1X2D22 US Manufacturing
Filings indexed 793 across all filing types
Latest filing 2021-08-12 Interim / Quarterly Rep…
Country US United States of America
Listing US CDTX

About Cidara Therapeutics, Inc.

https://www.cidara.com/

Cidara Therapeutics, Inc. is a biotechnology company that develops targeted immunotherapies and novel anti-infectives for patients with serious diseases. The company utilizes its proprietary Cloudbreak® platform to create drug-Fc conjugates (DFCs). These DFCs are engineered as 'single molecule cocktails' by coupling targeted small molecules or peptides to a human antibody fragment (Fc). This approach is designed to directly inhibit disease targets, such as fungal or viral pathogens, while simultaneously engaging the patient's immune system. The company's focus is on developing therapies for the treatment and prevention of life-threatening infections and other serious conditions.

Recent filings

Filing Released Lang Actions
CIDARA THERAPEUTICS, INC. FORM 10-Q
Interim / Quarterly Report Q2 2021
2021-08-12 English
SC 13D/A
Major Shareholding Notification
2021-08-12 English
FORM 4
Director's Dealing
2021-07-31 English
FORM 4
Director's Dealing
2021-07-31 English
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated July 16, 2021, reporting the resignation of a Chief Business Officer and related transition arrangements. The content focuses on a change in senior management personnel. There are no financial statements, earnings data, or detailed reports. The key section is Item 5.02, which pertains to departure and appointment of officers. This matches the definition of Board/Management Information (MANG). The document length is 3117 characters, which is consistent with a typical 8-K filing for management changes. Therefore, the classification is MANG with high confidence.
2021-07-20 English
FORM 3 SUBMISSION
Director's Dealing
2021-07-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.